Seven Editora
##common.pageHeaderLogo.altText##
##common.pageHeaderLogo.altText##

Contact

  • Seven Publicações Ltda CNPJ: 43.789.355/0001-14 Rua: Travessa Aristides Moleta, 290- São José dos Pinhais/PR CEP: 83045-090
  • Principal Contact
  • Nathan Albano Valente
  • (41) 9 8836-2677
  • editora@sevenevents.com.br
  • Support Contact
  • contato@sevenevents.com.br

Use of CBD for treatment of anxiety and depression

  • 1139-1143
  • 23/04/2024
  • 23/04/2024
Simões DVSS;
Freitas JF;
Martins HC

Deise Vimaana Santos de Souza Simões

João Fábio de Freitas

Hyan Coelho Martins

Keywords

CBD
Anxiety
Depression
Cannabidiol
Treatment
Literature review
Mechanisms of action
Clinical evidence
Safety
Regulation

Abstract

This literature review article explores the use of cannabidiol (CBD) in the treatment of anxiety and depression. It analyzes CBD's mechanisms of action, clinical evidence, efficacy, safety, and regulation. Anxiety and depression are common disorders, and CBD has been highlighted as a possible therapy. CBD acts on the endocannabinoid system and the serotonergic system. Clinical studies show reduced social anxiety and antidepressant effects. However, research is still preliminary, and effectiveness may vary. CBD has a favorable safety profile but can cause mild side effects. Regulation varies between countries, so it is essential to be aware of local laws.

 

DOI:https://doi.org/10.56238/sevened2024.007-084

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2024 Deise Vimaana Santos de Souza Simões , João Fábio de Freitas , Hyan Coelho Martins
Chapter 84
Versão (Português (Brasil))

Author(s)

  • Deise Vimaana Santos de Souza Simões
  • João Fábio de Freitas
  • Hyan Coelho Martins